Abbott stock tumbled to a month-low Friday after an Illinois jury ordered Reckitt Benckiser to pay $60 million in an infant formula lawsuit.

The post Why Abbott’s Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst appeared first on Investor’s Business Daily.